Get started
Author

Marta Pojo

Observed names: M Pojo, M. Pojo, Pojo, Marta
ORCID: 0000-0002-4036-6731
Observed ORCID: 0000-0002-4036-6731
OpenAlex ID: A5030104442
Hypoxia-mediated upregulation of MCT1 expression supports the glycolytic phenotype of glioblastomas
2016 · Vera Miranda-Gonçalves, Sara Granja, et al. · Oncotarget · 136
PDF
Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylation
2019 · Cheila Brito, Ana Azevedo, et al. · BMC Cancer · 93
PDF
Therapeutic targeting of PD-1/PD-L1 blockade by novel small-molecule inhibitors recruits cytotoxic T cells into solid tumor microenvironment
2022 · Rita C. Acúrcio, Sabina Pozzi, et al. · Journal for ImmunoTherapy of Cancer · 62
PDF
A transcriptomic signature mediated by HOXA9 promotes human glioblastoma initiation, aggressiveness and resistance to temozolomide
2015 · Marta Pojo, Céline S. Gonçalves, et al. · Oncotarget · 62
PDF
The Dark Side of Melanin Secretion in Cutaneous Melanoma Aggressiveness
2022 · Luís C. Cabaço, Ana Tomás, et al. · Frontiers in Oncology · 61
The long non-coding RNAHOTAIRis transcriptionally activated by HOXA9 and is an independent prognostic marker in patients with malignant glioma
2018 · Ana Xavier-Magalhães, Céline S. Gonçalves, et al. · Oncotarget · 47
PDF
Effects of the functional HOTAIR rs920778 and rs12826786 genetic variants in glioma susceptibility and patient prognosis
2017 · Ana Xavier-Magalhães, Ana I. Oliveira, et al. · Journal of Neuro-Oncology · 47
WNT6 is a novel oncogenic prognostic biomarker in human glioblastoma
2018 · Céline S. Gonçalves, Joana Vieira de Castro, et al. · Theranostics · 43
PDF
Take Advantage of Glutamine Anaplerosis, the Kernel of the Metabolic Rewiring in Malignant Gliomas
2020 · Filipa Martins, Luís G. Gonçalves, et al. · Biomolecules · 35
PDF
Melanoma Metabolism: Cell Survival and Resistance to Therapy
2020 · Rafael Luís, Cheila Brito, et al. · Advances in experimental medicine and biology · 27
Nobiletin Alone or in Combination with Cisplatin Decreases the Viability of Anaplastic Thyroid Cancer Cell Lines
2019 · Diana P. Sousa, Marta Pojo, et al. · Nutrition and Cancer · 26
The efficacy of HRAS and CDK4/6 inhibitors in anaplastic thyroid cancer cell lines
2018 · S. Lopes-Ventura, M. Pojo, et al. · Journal of Endocrinological Investigation · 25
PIK3CA Mutations in Diffuse Gliomas: An Update on Molecular Stratification, Prognosis, Recurrence, and Aggressiveness
2022 · Cheila Brito, Ana Tomás, et al. · Clinical Medicine Insights Oncology · 24
Transcriptional profiling of HOXA9-regulated genes in human glioblastoma cell models
2015 · Céline S. Gonçalves, Ana Xavier-Magalhães, et al. · Genomics Data · 24
PDF
High-Throughput Sequencing Identifies 3 Novel Susceptibility Genes for Hereditary Melanoma
2020 · Catarina Campos, Sofia Fragoso, et al. · Genes · 21
PDF
Cadherin‐3 is a novel oncogenic biomarker with prognostic value in glioblastoma
2021 · Eduarda P. Martins, Céline S. Gonçalves, et al. · Molecular Oncology · 16
Identification of SPRY4 as a Novel Candidate Susceptibility Gene for Familial Nonmedullary Thyroid Cancer
2021 · Inês J. Marques, Inês Gomes, et al. · Thyroid · 16
Unraveling the Relevance of ARL GTPases in Cutaneous Melanoma Prognosis through Integrated Bioinformatics Analysis
2021 · Cheila Brito, Bruno Costa-Silva, et al. · International Journal of Molecular Sciences · 15
PDF
Identification of novel candidate predisposing genes in familial nonmedullary thyroid carcinoma implicating DNA damage repair pathways
2024 · Carolina Pires, Inês J. Marques, et al. · International Journal of Cancer · 14
PDF
The Impact of Olive Oil Compounds on the Metabolic Reprogramming of Cutaneous Melanoma Cell Models
2021 · Cheila Brito, Ana Tomás, et al. · Molecules · 14
PDF
In vitro evaluation of the cytotoxicity and cellular uptake of CMCht/PAMAM dendrimer nanoparticles by glioblastoma cell models
2013 · M. Pojo, S. R. Cerqueira, et al. · Journal of Nanoparticle Research · 12
Molecular Hallmarks of Gliomas
2011 · Marta Pojo, Bruno Marques · InTech eBooks · 12
PDF
BRD9 status is a major contributor for cysteine metabolic remodeling through MST and EAAT3 modulation in malignant melanoma
2023 · Ana Hipólito, Renato Xavier, et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 11
PDF
Clinical and molecular characterisation of metastatic papillary thyroid cancer according to radioiodine therapy outcomes
2023 · Joana Simões-Pereira, Ana Saramago, et al. · Endocrine · 10
PIK3CA Mutations: Are They a Relevant Target in Adult Diffuse Gliomas?
2025 · Ana Tomás, Marta Pojo · International Journal of Molecular Sciences · 8
PDF
Works count: 50
Citation count: 900
H-index: 16
I10-index: 24
Year
Topic
Type